XML 69 R38.htm IDEA: XBRL DOCUMENT v3.25.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Provision For (Benefit From) Income Taxes
Loss before income taxes for the years ended December 31, 2025 and 2024 consisted of the following (in thousands):
YEAR ENDED DECEMBER 31,
20252024
United States$74,804 $(189,315)
Foreign17,093 2,262 
Income (loss) before income taxes
$91,897 $(187,053)
Schedule of Components of Income Tax Expense (Benefit)
The components of the provision for income taxes for the years ended December 31, 2025 and 2024 consisted of the following (in thousands):
YEAR ENDED DECEMBER 31,
20252024
Current income tax provision:
Federal$— $— 
State— — 
Foreign4,883 300 
Total current income tax provision
$4,883 $300 
Total deferred income tax provision
$— $— 
Total income tax provision
$4,883 $300 
Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate to Effective Income Tax Rate
The following is a reconciliation of the Company’s U.S. federal statutory income tax rate to the Company’s effective income tax rate for the years ended December 31, 2025 in accordance with the guidance in the ASU No. 2023-09, which the Company has elected to prospectively adopt:
YEAR ENDED DECEMBER 31,
2025
U.S Federal statutory tax rate$19,298 21.0 %
State and local income tax, net of federal income tax effect2734 0.8 
Foreign tax effects
Australia
Difference between local tax rare and U.S. federal statutory tax rate1,538 1.7 
Other(245)(0.3)
Effect of changes in taw laws or rates enacted in the current period— — 
Effect of cross-border tax laws— — 
Tax credits
Research and development tax credits13,664 14.9 
Changes in valuation allowances(33,331)(36.3)
Nontaxable or nondeductible items
Nondeductible executive compensation5,048 5.5 
Stock compensation1,263 1.4 
Other — 
Changes in unrecognized tax benefits(2,784)(3.0)
Other(308)(0.4)
Effective tax rate$4,883 5.3 %
The following is a reconciliation of the Company’s U.S. federal statutory income tax rate to the Company’s effective income tax rate for the year ended December 31, 2024 prior to adoption of ASU No. 2023-09:
YEAR ENDED DECEMBER 31,
2024
Income at U.S. statutory rate21.0 %
State taxes8.8 
Stock compensation(0.6)
Other permanent differences(1.3)
Research and development credits1.2 
Impact of foreign operations(0.1)
Foreign withholding taxes(0.2)
Other(3.2)
Tax credits1.2 
Change in valuation allowance(27.0)
Effective tax rate(0.2)%
Schedule of Net Deferred Tax Assets
The net deferred income tax asset balance as of December 31, 2025 and 2024 related to the following (in thousands):
YEAR ENDED DECEMBER 31,
20252024
Net operating loss carryforwards$35,141 $45,084 
Research and development tax credits409 16,184 
Capitalized research and development expenses53,477 78,413 
Stock-based compensation7,667 7,558 
Operating lease liability4,620 5,068 
Accrued expenses1,447 2,626 
Other79 269 
Total deferred tax assets$102,840 $155,202 
Valuation allowance$(97,991)$(150,037)
Net deferred tax assets$4,849 $5,165 
Deferred tax liability
Operating lease right-of-use asset(4,608)(5,165)
Other(241)
Net deferred tax assets
$— $—